Advagraf + Prograf + Prograf
ApprovedCompleted 1 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Liver Transplantation
Conditions
Liver Transplantation
Trial Timeline
Apr 27, 2011 → May 27, 2014
NCT ID
NCT01339468About Advagraf + Prograf + Prograf
Advagraf + Prograf + Prograf is a approved stage product being developed by Astellas Pharma for Liver Transplantation. The current trial status is completed. This product is registered under clinical trial identifier NCT01339468. Target conditions include Liver Transplantation.
What happened to similar drugs?
20 of 20 similar drugs in Liver Transplantation were approved
Approved (20) Terminated (3) Active (0)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01339468 | Approved | Completed |
Competing Products
20 competing products in Liver Transplantation